Cargando…
Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies
Reverse-phase protein array (RPPA) technology uses panels of high-specificity antibodies to measure proteins and protein post-translational modifications in cells and tissues. The approach offers sensitive and precise quantification of large numbers of samples and has thus found applications in the...
Autores principales: | Byron, Adam, Bernhardt, Stephan, Ouine, Bérèngere, Cartier, Aurélie, Macleod, Kenneth G., Carragher, Neil O., Sibut, Vonick, Korf, Ulrike, Serrels, Bryan, de Koning, Leanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738515/ https://www.ncbi.nlm.nih.gov/pubmed/33319783 http://dx.doi.org/10.1038/s41598-020-77335-0 |
Ejemplares similares
-
Analysis of Reverse Phase Protein Array Data: From Experimental Design towards Targeted Biomarker Discovery
por: Wachter, Astrid, et al.
Publicado: (2015) -
Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
por: Lièvre, Astrid, et al.
Publicado: (2018) -
Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
por: Lièvre, Astrid, et al.
Publicado: (2017) -
Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array
por: Partolina, Marina, et al.
Publicado: (2017) -
Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition
por: El Botty, Rania, et al.
Publicado: (2018)